4.3 Review

Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

The Updated EAU Guidelines on Muscle-Invasive and Metastatic Madder Cancer

Arnulf Stenzl et al.

EUROPEAN UROLOGY (2009)

Review Urology & Nephrology

Epidemiology and genetic susceptibility to bladder cancer

Xifeng Wu et al.

BJU INTERNATIONAL (2008)

Review Urology & Nephrology

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

Marko Babjuk et al.

EUROPEAN UROLOGY (2008)

Article Oncology

Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail

Fredrik Liedberg et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)

Article Urology & Nephrology

Bladder cancer: Epidemiology, staging and grading, and diagnosis

Z Kirkali et al.

UROLOGY (2005)

Article Urology & Nephrology

erbB receptor expression patterns in human bladder cancer

PH Rajjayabun et al.

UROLOGY (2005)

Article Oncology

HER-2 and TOP2A coamplification in urinary bladder cancer

R Simon et al.

INTERNATIONAL JOURNAL OF CANCER (2003)

Article Urology & Nephrology

Prognostic values of p53 and HER-2/neu coexpression in invasive bladder cancer in Taiwan

YS Tsai et al.

UROLOGIA INTERNATIONALIS (2003)